Acnatac, Gel

7680625130011 CH-62513 Gel

Associated product:

ACNATAC gel tb 30 g
Acnatac, Gel
Acnatac, Gel
Acnatac, Gel
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/05/2024
Patient information leaflet
Français
06/05/2024
Patient information leaflet
Italien
06/05/2024
Summary of Product Characteristics
Allemand
06/05/2024
Summary of Product Characteristics
Français
06/05/2024
Summary of Product Characteristics
Italien
06/05/2024

Detailed composition

Substance Quantity Type Category
clindamycini phosphas
12.0 MG Substance WIZUS
clindamycinum
10.0 MG Substance Wirkstoff (Principe actif)
tretinoinum
0.25 MG Substance Wirkstoff (Principe actif)
acidum citricum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
trometamolum
- Substance HNIDK
carbomerum 981
- Substance HNIDK
glycerolum
- Substance HNIDK
E 321
0.2 MG Substance HBESI
propylis parahydroxybenzoas
0.3 MG Substance HBESI
E 218
1.5 MG Substance HBESI
aqua purificata
- Substance HNIDK

Reimbursement information

Public price
CHF 32.85
Specialties list
Yes
Generic
No
SL addition date: 01/12/2016

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
62513
Drug name
Acnatac, Gel
Galenic form
GELK
ATC Code
D10AF51
Authorization status
Z
Dispensing category
A
First authorization
28/03/2014
Authorization expiration date
31/12/9999
IT Number
10.02.0.
Domain
Human medicine
Field of application
Topische Behandlung von Akne vulgaris

Package details

Description (FR)
ACNATAC gel tb 30 g
Description (DE)
ACNATAC Gel Tb 30 g
Market launch
28/03/2014
Narcotic (BTM)
No
Buy us a coffee Explore the data